ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.66B
1-Year Est. Return 340.85%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+340.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.66B
AUM Growth
+$327M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
329
New
Increased
Reduced
Closed

Top Buys

1
+$40.1M
2
+$37.1M
3
+$36.2M
4
INSP icon
Inspire Medical Systems
INSP
+$27.3M
5
VIR icon
Vir Biotechnology
VIR
+$21.9M

Top Sells

1
+$39.4M
2
+$17.3M
3
+$13.2M
4
FULC icon
Fulcrum Therapeutics
FULC
+$10.4M
5
ABUS icon
Arbutus Biopharma
ABUS
+$9.98M

Sector Composition

1 Healthcare 90.27%
2 Financials 1.54%
3 Technology 0.08%
4 Industrials 0.08%
5 Materials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FULC icon
151
Fulcrum Therapeutics
FULC
$461M
$1M 0.06%
130,560
-1,123,189
BCRX icon
152
BioCryst Pharmaceuticals
BCRX
$2.26B
$1,000K 0.06%
105,000
+60,000
GH icon
153
Guardant Health
GH
$17.2B
$924K 0.06%
10,000
+3,000
CBIO
154
Crescent Biopharma
CBIO
$569M
$924K 0.06%
50,273
-555,727
CNTX icon
155
Context Therapeutics
CNTX
$262M
$920K 0.06%
351,094
ENGN icon
156
enGene Therapeutics
ENGN
$124M
$910K 0.05%
133,686
-170,000
SLN
157
Silence Therapeutics
SLN
$326M
$907K 0.05%
172,157
+148,514
ARE icon
158
Alexandria Real Estate Equities
ARE
$8.66B
$905K 0.05%
19,500
+3,200
IBIO icon
159
iBio
IBIO
$94.4M
$893K 0.05%
469,878
+64,347
BNTX icon
160
BioNTech
BNTX
$24.3B
$889K 0.05%
10,000
GILD icon
161
Gilead Sciences
GILD
$167B
$885K 0.05%
6,351
-315
NRIX icon
162
Nurix Therapeutics
NRIX
$1.84B
$869K 0.05%
56,070
-16,000
DYN icon
163
Dyne Therapeutics
DYN
$3.2B
$861K 0.05%
47,463
+4,789
ISRG icon
164
Intuitive Surgical
ISRG
$150B
$844K 0.05%
1,830
+810
ANL
165
Adlai Nortye
ANL
$769M
$816K 0.05%
+117,909
WW
166
WW International
WW
$166M
$793K 0.05%
57,700
+600
RNA
167
Atrium Therapeutics
RNA
$222M
$771K 0.05%
+57,688
ITGR icon
168
Integer Holdings
ITGR
$3.03B
$770K 0.05%
+8,750
KPTI icon
169
Karyopharm Therapeutics
KPTI
$206M
$762K 0.05%
136,736
+86,736
CMPX icon
170
Compass Therapeutics
CMPX
$429M
$735K 0.04%
139,000
NUVL icon
171
Nuvalent
NUVL
$8.72B
$711K 0.04%
6,942
+100
CGEM icon
172
Cullinan Oncology
CGEM
$1.01B
$711K 0.04%
50,000
IDYA icon
173
IDEAYA Biosciences
IDYA
$2.59B
$666K 0.04%
20,000
ENTA icon
174
Enanta Pharmaceuticals
ENTA
$383M
$649K 0.04%
51,357
+10,000
VERA icon
175
Vera Therapeutics
VERA
$2.55B
$645K 0.04%
16,033
+1,300
5 6
7
8 9